Synergy Research Group Joins the European Forum for Good Clinical Practice
Synergy Research Group (SynRG) has become the first Russian member of the European Forum for Good Clinical Practice (EFGCP). Founded in 1993, EFGCP aims to promote Good Clinical Practice and high-quality biomedical research throughout Europe.
“These goals and objectives are very much in line with our own long-term strategies, so we’d be very pleased to join our efforts with EFGCP,” said Igor Stefanov, SynRG General Manager, in a press release.
From the beginning of its membership, SynRG became involved in EFGCP activities and plans on integrating Russia into European R&D community. In December, an EFGCP Board Meeting endorsed a plan to include Russia in the area of EFGCP influence, and, as a result to establish a trustworthy reputation of Russia as a peer ethical partner among the International Clinical Research Community.
“Being a natural member of European family; de-jure as a formal non-member of EU; and de-facto as a terra incognita for most Europeans, Russia suffers from this triple nature, as a result of ignorance, misinterpretation, and lack of trust and rapport from the European community. We are keen to change this situation,” said Igor Stefanov in that same press release.
For more on the collaboration between SynRG and EFGCP, click here.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
